INFOSYS LIMITED vs iSERA Lifesciences Ltd
A side-by-side comparison of INFOSYS LIMITED (INFY) and iSERA Lifesciences Ltd (ISERA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, INFOSYS LIMITED leads INFY vs ISERA on 12 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability40
- Growth· not comparable—
- Size & financial health40
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
INFY takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
INFY takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
INFY takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Stock is providing a good dividend yield of 4.20%.", "Company has a good return on equity (ROE) track record: 3 Years ROE 30.8%", "Company has been maintaining a healthy dividend payout of 68.5%", "Company's working capital requirements have reduced from 42.0 days to 32.7 days"]
- − ["Promoter holding has decreased over last quarter: -0.56%", "Promoter holding is low: 13.8%"]
- − ["Stock is trading at 14.7 times its book value", "Company has high debtors of 322 days.", "Promoter holding has decreased over last 3 years: -41.4%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.